Zuclopenthixol decanoate dihydrochloride is an antipsychotic medication primarily used in the treatment of schizophrenia and other psychotic disorders. It is a long-acting formulation of zuclopenthixol, which is a thioxanthene derivative. This compound is characterized by its ability to block dopamine receptors in the brain, thereby helping to alleviate symptoms of psychosis. The dihydrochloride form indicates that the substance is a salt, enhancing its solubility and stability. Zuclopenthixol decanoate is typically administered via intramuscular injection, allowing for prolonged therapeutic effects due to its slow release into the bloodstream. The pharmacokinetics of this compound involve a long half-life, which supports less frequent dosing compared to oral formulations. Common side effects may include sedation, weight gain, and extrapyramidal symptoms, which are typical of antipsychotic medications. As with any medication, it is essential to monitor patients for adverse effects and adjust dosages accordingly. Overall, zuclopenthixol decanoate dihydrochloride plays a significant role in managing chronic psychiatric conditions.

ZUCLOPENTHIXOL DECANOATE DIHYDROCHLORIDE

1448876-93-4: Zuclopenthixol decanoate dihydrochloride is an antipsychotic medication primarily used in the treatment of schizophrenia and other psychotic disorders. It is a long-acting formulation of zuclopenthixol, which is a thioxanthene derivative. This compound is characterized by its ability to block dopamine receptors in the brain, thereby helping to alleviate symptoms of psychosis. The dihydrochloride form indicates that the substance is a salt, enhancing its solubility and stability. Zuclopenthixol decanoate is typically administered via intramuscular injection, allowing for prolonged therapeutic effects due to its slow release into the bloodstream. The pharmacokinetics of this compound involve a long half-life, which supports less frequent dosing compared to oral formulations. Common side effects may include sedation, weight gain, and extrapyramidal symptoms, which are typical of antipsychotic medications. As with any medication, it is essential to monitor patients for adverse effects and adjust dosages accordingly. Overall, zuclopenthixol decanoate dihydrochloride plays a significant role in managing chronic psychiatric conditions.

CAS 1448876-93-4

ZUCLOPENTHIXOL DECANOATE DIHYDROCHLORIDE

Zuclopenthixol Decanoate Dihydrochloride

Ref: ST-EA-CP-Z26001